Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2022-12-12 History
Report ID 31631
Drug Identification Number 02407515
Brand name TARO-CARBAMAZEPINE
Common or Proper name TARO CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500's
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-12-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v56 2021-10-21 French Compare
v55 2021-10-21 English Compare
v54 2021-10-13 French Compare
v53 2021-10-13 English Compare
v52 2021-09-15 French Compare
v51 2021-09-15 English Compare
v50 2021-08-24 French Compare
v49 2021-08-24 English Compare
v48 2021-08-20 French Compare
v47 2021-08-20 English Compare
v46 2021-08-04 French Compare
v45 2021-08-04 English Compare
v44 2019-08-19 French Compare
v43 2019-08-19 English Compare
v42 2019-04-23 English Compare
v41 2019-04-23 English Compare
v40 2019-04-15 French Compare
v39 2019-04-15 English Compare
v38 2019-03-15 French Compare
v37 2019-03-15 English Compare

Showing 21 to 40 of 76